“Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s728. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/4041.